Intra Cellular Therapies | ITCI - Employees Total Number


Intra Cellular Therapies reported 860 in Employees for its fiscal year ending in December of 2024.



Employees Change Date
Acadia Pharmaceuticals 653 56 Dec/2024
ALKERMES 1.8K 300 Dec/2024
BioCryst Pharmaceuticals 536 5 Dec/2023
Biogen 7.6K 35 Dec/2024
Bristol-Myers Squibb 34.1K 0 Dec/2024
Cytokinetics 498 75 Dec/2024
Esperion Therapeutics 240 41 Dec/2023
Gilead Sciences 17.6K 400 Dec/2024
Halozyme Therapeutics 350 23 Dec/2024
J&J 138.1K 6.2K Dec/2024
Minerva Neurosciences 9 0 Dec/2023
Nektar Therapeutics 137 79 Dec/2023
Neurocrine Biosciences 1.8K 400 Dec/2024
Novartis 101.7K 2.62K Dec/2022
Prothena 163 10 Dec/2024
RedHill Biopharma 113 88 Dec/2022
Supernus Pharmaceuticals 674 22 Dec/2024
United Therapeutics 1.3K 137 Dec/2024
Vanda Pharmaceuticals 203 87 Dec/2023